Cargando…

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States

Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using mortality data from the National Vital Statistics System multiple‐cause mortality data (2007‐2016). Decedents who had NAFLD were identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Paik, James M., Henry, Linda, De Avila, Leyla, Younossi, Elena, Racila, Andrei, Younossi, Zobair M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824058/
https://www.ncbi.nlm.nih.gov/pubmed/31701070
http://dx.doi.org/10.1002/hep4.1419
_version_ 1783464663169630208
author Paik, James M.
Henry, Linda
De Avila, Leyla
Younossi, Elena
Racila, Andrei
Younossi, Zobair M.
author_facet Paik, James M.
Henry, Linda
De Avila, Leyla
Younossi, Elena
Racila, Andrei
Younossi, Zobair M.
author_sort Paik, James M.
collection PubMed
description Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using mortality data from the National Vital Statistics System multiple‐cause mortality data (2007‐2016). Decedents who had NAFLD were identified by International Classification of Diseases (ICD) codes K75.81, K76.0, K74.0, K74.6, and K76.9. Among NAFLD decedents, cause‐specific deaths (e.g., cardiovascular disease [CVD], cirrhosis, hepatocellular carcinoma [HCC], non‐liver cancer, diabetes mellitus [DM]) were identified by underlying cause of death ICD‐10 codes. Trends were evaluated by average annual percentage change (AAPC) in age‐standardized death rate (ASDR) per 100,000 persons. Among the 25,129,960 decedents aged ≥20 years, 353,234 (1.4%) decedents had NAFLD (212,322 men; 260,765 non‐Hispanic whites, 32,868 non‐Hispanic blacks, 46,530 Hispanics, 5,025 non‐Hispanic American Indian or Alaska Natives [AIANs], 7,023 non‐Hispanic Asian or Pacific Islanders [APIs]), with a mean age at death of 64.47 ± 13.17 years. During the study period, the ASDR for NAFLD increased by 15% (12.94 to 14.90; AAPC, 1.98%; P < 0.001]), while women (AAPC, 2.99% vs. 1.16% men; P = 0.003), non‐Hispanic whites (AAPC, 2.48%), non‐Hispanic AIANs (AAPC, 2.31%), and Hispanics (AAPC, 0.74%) experienced the highest annual increases. Stable trends were noted for non‐Hispanic blacks and non‐Hispanic APIs. Among subgroups, Mexican (AAPC, 1.75%) and Asian Indians (AAPC, 6.94%) experienced annual increases. The top six underlying causes of death (155,894 cirrhosis, 38,444 CVD, 19,466 non‐liver cancer, 10,867 HCC, 8,113 DM, and 5,683 lung disease) accounted for 67.5% of NAFLD‐related deaths. For cause‐specific deaths, ASDR increased for HCC (AAPC, 3.82%), DM (AAPC, 2.23%), non‐liver cancer (AAPC, 2.14%), CVD (AAPC, 1.59%), and cirrhosis (AAPC, 0.96%). Conclusion: NAFLD‐related deaths in U.S. adults are increasing. Cirrhosis is the top cause‐specific death, followed by CVD. Women, non‐Hispanic whites, and non‐Hispanic AIANs (subgroups Mexicans and Asian Indians) experienced the highest increases in deaths. Policies addressing the societal burden of NAFLD are needed.
format Online
Article
Text
id pubmed-6824058
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68240582019-11-07 Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States Paik, James M. Henry, Linda De Avila, Leyla Younossi, Elena Racila, Andrei Younossi, Zobair M. Hepatol Commun Original Articles Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using mortality data from the National Vital Statistics System multiple‐cause mortality data (2007‐2016). Decedents who had NAFLD were identified by International Classification of Diseases (ICD) codes K75.81, K76.0, K74.0, K74.6, and K76.9. Among NAFLD decedents, cause‐specific deaths (e.g., cardiovascular disease [CVD], cirrhosis, hepatocellular carcinoma [HCC], non‐liver cancer, diabetes mellitus [DM]) were identified by underlying cause of death ICD‐10 codes. Trends were evaluated by average annual percentage change (AAPC) in age‐standardized death rate (ASDR) per 100,000 persons. Among the 25,129,960 decedents aged ≥20 years, 353,234 (1.4%) decedents had NAFLD (212,322 men; 260,765 non‐Hispanic whites, 32,868 non‐Hispanic blacks, 46,530 Hispanics, 5,025 non‐Hispanic American Indian or Alaska Natives [AIANs], 7,023 non‐Hispanic Asian or Pacific Islanders [APIs]), with a mean age at death of 64.47 ± 13.17 years. During the study period, the ASDR for NAFLD increased by 15% (12.94 to 14.90; AAPC, 1.98%; P < 0.001]), while women (AAPC, 2.99% vs. 1.16% men; P = 0.003), non‐Hispanic whites (AAPC, 2.48%), non‐Hispanic AIANs (AAPC, 2.31%), and Hispanics (AAPC, 0.74%) experienced the highest annual increases. Stable trends were noted for non‐Hispanic blacks and non‐Hispanic APIs. Among subgroups, Mexican (AAPC, 1.75%) and Asian Indians (AAPC, 6.94%) experienced annual increases. The top six underlying causes of death (155,894 cirrhosis, 38,444 CVD, 19,466 non‐liver cancer, 10,867 HCC, 8,113 DM, and 5,683 lung disease) accounted for 67.5% of NAFLD‐related deaths. For cause‐specific deaths, ASDR increased for HCC (AAPC, 3.82%), DM (AAPC, 2.23%), non‐liver cancer (AAPC, 2.14%), CVD (AAPC, 1.59%), and cirrhosis (AAPC, 0.96%). Conclusion: NAFLD‐related deaths in U.S. adults are increasing. Cirrhosis is the top cause‐specific death, followed by CVD. Women, non‐Hispanic whites, and non‐Hispanic AIANs (subgroups Mexicans and Asian Indians) experienced the highest increases in deaths. Policies addressing the societal burden of NAFLD are needed. John Wiley and Sons Inc. 2019-08-14 /pmc/articles/PMC6824058/ /pubmed/31701070 http://dx.doi.org/10.1002/hep4.1419 Text en © 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Paik, James M.
Henry, Linda
De Avila, Leyla
Younossi, Elena
Racila, Andrei
Younossi, Zobair M.
Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title_full Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title_fullStr Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title_full_unstemmed Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title_short Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
title_sort mortality related to nonalcoholic fatty liver disease is increasing in the united states
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824058/
https://www.ncbi.nlm.nih.gov/pubmed/31701070
http://dx.doi.org/10.1002/hep4.1419
work_keys_str_mv AT paikjamesm mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates
AT henrylinda mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates
AT deavilaleyla mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates
AT younossielena mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates
AT racilaandrei mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates
AT younossizobairm mortalityrelatedtononalcoholicfattyliverdiseaseisincreasingintheunitedstates